IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q1 2025 Holdings

Filed 2025-05-02 | 4 holdings | $138.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$70.6M2,936,50750.8%
Cytokinetics, Inc(CYTK)COM23282W605$39.4M980,39228.4%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$28.8M3,846,15420.8%
Viracta Therapeutics IncCOM92765F108$743,7000.0%